Nachrichten zur Biodelivery Sciences International Inc. Aktie

XFRA : Deletion of Instruments from Boerse Frankfurt - 22.03.2022

The following instruments on Boerse Frankfurt do have their last trading day on 22.03.2022 Die folgenden Instrumente in Boerse Frankfurt haben…

Form 8-K BIODELIVERY SCIENCES For: Mar 22

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 10-K BIODELIVERY SCIENCES For: Dec 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Earnings Preview: BioDelivery Sciences International (BDSI) Q4 Earnings Expected to Decline

BioDelivery (BDSI) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming…

Has Hepion Pharmaceuticals, Inc. (HEPA) Outpaced Other Medical Stocks This Year?

Here is how Hepion Pharmaceuticals, Inc. (HEPA) and BioDelivery Sciences International (BDSI) have performed compared to their sector so far…

BioDelivery Sciences launches migraine therapy in U.S.

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BioDelivery Sciences International Announces ELYXYB™ is Now Available in the U.S. for the Acute Treatment of Migraine

The First and Only FDA-Approved, Ready-to-Use Oral Solution for the Acute Treatment of Migraine with or without Aura in Adults...…

Biotech Stock Roundup: BDSI Surges on Merger Deal, SGEN Down on Outlook & More

Merger updates from BioDelivery (BDSI) and Seagen (SGEN) earnings results are among a few key highlights from the biotech sector…

Form 8-K/A BIODELIVERY SCIENCES For: Feb 13

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

SHAREHOLDER ALERT: WeissLaw LLP Investigates BioDelivery Sciences International, Inc.

NEW YORK, Feb. 15, 2022 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of…

BioDelivery (BDSI) Stock Surges on Buyout Offer From Collegium

Collegium (COLL) is set to acquire BioDelivery (BDSI) for approximately $604 million in cash. The transaction is likely to be…

BioDelivery Sciences Buyout Is Good, Not Great

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Mid-Day Market Update: Gold Rises 1%; BioDelivery Sciences International Shares Spike Higher

US stocks remained mixed midway through trading on Monday amid rising tensions on the border of Russia and Ukraine. The…

Collegium Pharma Shares Rise 15% After BioDelivery Sciences Buyout Offer

Collegium Pharma Shares Rise 15% After BioDelivery Sciences Buyout Offer...…

Shareholder Alert: Ademi LLP investigates whether BioDelivery Sciences International, Inc. has obtained a Fair Price in its transaction with Collegium.

MILWAUKEE, Feb. 14, 2022 /PRNewswire/ -- Ademi LLP is investigating BioDelivery Sciences (NASDAQ: BDSI) for possible breaches of fiduciary duty…

Form 8-K BIODELIVERY SCIENCES For: Feb 13

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Collegium Pharma Broadens Its Pain Portfolio With $600M BioDelivery Sciences Deal

Collegium Pharmaceutical Inc (NASDAQ: COLL) will acquire BioDelivery Sciences International Inc (NASDAQ: BDSI) at $5.60 per share in an all-cash transaction, corresponding to…

Collegium Pharmaceutical to acquire BioDelivery Sciences for $5.60/share in all cash deal

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Collegium Pharmaceutical Buys BioDelivery Sciences for $5.60 a Share

Collegium Pharmaceutical Buys BioDelivery Sciences for $5.60 a Share...…

Collegium to Acquire BioDelivery Sciences Broadening Pain Portfolio

- Expected to be Immediately and Highly Accretive Driven by Identified Annual Synergies of at Least $75 Million -...…

Collegium to Acquire BioDelivery Sciences in an All-Cash Deal

Transaction is valued at $5.60 per share representing a total equity value of $604 million...…

Why the Earnings Surprise Streak Could Continue for BioDelivery (BDSI)

BioDelivery (BDSI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…

BioDelivery Sciences: Favorable Court Ruling Provides Tailwind

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Should Value Investors Pick BioDelivery (BDSI) Stock Now?

Lets see if BioDelivery (BDSI) stock is a good choice for value-oriented investors right now from multiple angles....…

BioDelivery (BDSI) Stock Up on Raised Guidance for 2021

BioDelivery Sciences International (BDSI) raises its financial guidance for full-year 2021. BDSI expects sales at the high end of its…

BioDelivery Sciences rises on upside 2021 guidance

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K BIODELIVERY SCIENCES For: Jan 20

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

BioDelivery Sciences lower as Alvogen plans to challenge court ruling on pain killer

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why BioDelivery Sciences International Stock Was Up 28.5% Monday

The biotech company received a favorable court ruling regarding its lead therapy....…

BioDelivery Sciences posts a record gain after favorable court ruling

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BioDelivery Sciences: Current Lows Could Be An Opportunity

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Insiderhandel: Aufsichtsrat kauft Aktien von BioDelivery Sciences International im Wert von 30.400$

Sirgo, Mark A. - Aufsichtsrat - Tag der Transaktion: 2021-11-18...…

BioDelivery Sciences International, Inc. 2021 Q3 - Results - Earnings Call Presentation

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BioDelivery Sciences International, inc (BDSI) Q3 2021 Earnings Call Transcript

BDSI earnings call for the period ending October 31, 2021....…

BioDelivery Sciences International (BDSI) Tops Q3 Earnings Estimates

BioDelivery (BDSI) delivered earnings and revenue surprises of 16.67% and -2.28%, respectively, for the quarter ended September 2021. Do the…

BioDelivery Sciences EPS beats by $0.01, misses on revenue

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BioDelivery Sciences Reports Solid Third Quarter 2021 Results

Total Net Revenue of $41.1 Million, an Increase of 4% versus Prior Year...…

BioDelivery Sciences Q3 2021 Earnings Preview

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Analysts Estimate BioDelivery Sciences International (BDSI) to Report a Decline in Earnings: What to Look Out for

BioDelivery (BDSI) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming…

BioDelivery Sciences International slips after revenue outlook disappoints

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BioDelivery Sciences International (BDSI) is a Top-Ranked Momentum Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why…

BioDelivery Sciences: Legal Fees Are Causing My Pain

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BioDelivery Sciences to Exhibit Three Scientific Posters Comparing BELBUCA® to Oxycodone at the PAINWeek 2021 Conference

RALEIGH, N.C., Sept. 07, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a growing specialty pharmaceutical company…

BioDelivery Sciences to Participate in Upcoming Virtual Investor Conferences

RALEIGH, N.C., Sept. 03, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty…

BioDelivery Sciences: Yet Another Buying Opportunity

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BioDelivery Sciences awarded $24 million contract from Dept. of Veteran Affairs

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BioDelivery Sciences International (BDSI) is a Top-Ranked Momentum Stock: Should You Buy?

Whether youre a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top…

BioDelivery Sciences International, inc (BDSI) Q2 2021 Earnings Call Transcript

BDSI earnings call for the period ending June 30, 2021....…

BIODELIVERY SCIENCES INTERNATIONAL INC: 10-Q Report

10-Q...…